Extended Data Fig. 1: Cohort overview and patient breakdown by analyses.
From: Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer
((a) Overview of the different sample sets used for the different analyses described in the manuscript, including sample sizes and reasons for exclusion. (b) Venn diagrams showing overlaps for patients with available MSK-IMPACT, WES, RNA-Seq and neoadjuvant therapy (NAT) outcome data. Color bars show the distribution of different relevant clinical variables. (c-h) Same as B, but restricted to the subset of patients used in specific analyses described in the manuscript. Thick red contours drawn on top of the Venn diagrams are used to highlight the set of patients used in each case. The G# in the titles refer to the columns found in Supplementary Table 1.
